Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
作者： Steven M. Albelda
DOI:
关键词: Biology 、 Chimeric antigen receptor 、 Molecular biology 、 Protein kinase A 、 Cancer
摘要:
wipo.int
lens.org参考文章(284)
Gary S. Gray, CD9 antigen peptides and antibodies thereto ,(1995)
Carl H. June, Daniel J. Powell, Use of a trans-signaling approach in chimeric antigen receptors ,(2013)
Ed Harlow, David Lane, Using Antibodies: A Laboratory Manual ,(1998)
Michael Jensen, Bispecific chimeric antigen receptors and therapeutic uses thereof ,(2013)
Steven Albelda, Carl H. June, John Scholler, Ellen Pure, Liang-Chuan Wang, Compositions and methods for targeting stromal cells for the treatment of cancer ,(2013)
Massimo Dominici, Maria Carlotta Spano, Dario Campana, Paolo Paolucci, Marco Bestagno, Sara Caldrer, A modified effector cell (or chimeric receptor) for treating disialoganglioside gd2 -expressing neoplasia ,(2012)
Andreas Plueckthun, Robert Waibel, Sergey Deyev, Multivalent complexes, their production and method of use ,(2005)
Herman Waldmann, Kathleen Nolan, Lynn Poulton, Treatment of obesity ,(2010)
Richard S. Blumberg, Yu-Hwa Huang, Nalan Utku, Anti-ceacam1 recombinant antibodies for cancer therapy ,(2012)
Solomon Langermann, Simultaneous inhibition of pd-l1/pd-l2 ,(2010)